Delivery Order SPE2DB24D2215-SPE2DB25FGSXP
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract is a firm fixed-price delivery order with a ceiling value of $2,063.61 and an ultimate completion date of May 7, 2025. The contract is not set aside for any specific business category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,651.72 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,948.70 and a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and a ceiling value of $8,761.71. It was awarded on April 16, 2025, with an ultimate completion date of April 17, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm fixed-price, $34,152.51 ceiling value, and an ultimate completion date of February 21, 2024. This contract award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product used for the treatment of overactive bladder. The contract has a ceiling value of $4,816.17 and runs until February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a branded medication used to treat overactive bladder. The firm fixed price contract has a ceiling value of $12,257.36 and a period of performance through February 10, 2022. Amerisourcebergen Drug Corp has an...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The contract is for the supply of Myrbetriq ER (mirabegron) 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,764.01 and runs through August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $12,154.60. It is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. The contract has a firm fixed price of $5,912.16 and a completion date of May 16, 2025. This delivery order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...